Clinical Trials Browser

Phase 2 × Carcinoma, Adenoid Cystic × enfortumab vedotin × Clear all

NCT06891560 2025-10-24

A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma

Phase 2 Recruiting

Carcinoma, Adenoid Cystic